Cisco Q3: Entering A Buy Zone From 2 Directions

Summary:

  • Cisco is scheduled to report its CY Q3 (or its Q1 FY 2023) earnings on Nov 16, 2022.
  • I expect its CY Q3 results to continue to be strained by component availability more than by weaker demand.
  • I will pay special attention to management’s comments on signs of the easing of supply headwinds, and to their comments about new/alternative suppliers.
  • In terms of valuation, the company is entering a buy zone from two independent assessments: the typical PE multiple and also an asset approach.

Cisco Systems Headquarters Office in San Jose, California

raisbeckfoto

Q3 preview and thesis

Cisco (NASDAQ:CSCO) is scheduled to report its CY Q3 (or its Q1 FY 2023) earnings report (“ER”) on Nov 16, 2022. I view its results in H1 of 2022 so far to be more choked by component availability than by

Chart, line chart Description automatically generated

Source: www.marketbeat.com

Graphical user interface, chart Description automatically generated

Source: Seeking Alpha data

Chart, line chart Description automatically generated

Source: author based on data from Yahoo Finance

Text Description automatically generated

Source: author based on Seeking Alpha data.


Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.


As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.

We have helped our members not only to beat S&P 500 but also avoid heavy drawdowns despite the extreme volatilities in BOTH the equity AND bond market.

Join for a 100% Risk-Free trial and see if our proven method can help you too.

Leave a Reply

Your email address will not be published. Required fields are marked *